The power of a very low cost basis.

$SAVA I’m so excited because my cost is average for my shares is $25.87 that’s why hahahahaha you have to be a Short and I’m semi retired hahahaha

$SAVA Mike cost this morning was $31.68 This morning not too bad

$COST almost!

$COST this dude 🤡🤣🤣🤣

$COST The bullish trend in the options market suggests a positive outlook for the stock We are seeing the $450 CALL having heavy activity which expire in 38 days.

$COST 💵long 💅

$COST 🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣

$COST nice wedge here 🫡🔒 all I gottta say 🤫

$COST Love Costco as much as anyone

$COST 2hr looking bullish, she wanna touch the 200 day which is 296, juicy

$COST The chart points towards an optimistic outlook for the stock.

$COST Always a buy in the 470s, congratulations to those who got it this a.m.

It’s not just the efficacy and safety of the product, it is the less cost for hospital/infusion, due to one hour infusion and the huge difference in price.

The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,

Each treatment cost under $10k per treatment.

Each treatment cost under $10k per treatment.

The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,